Do you have type 2 diabetes and are currently struggling to control your glucose levels?
This clinical research study is evaluating an experimental treatment for type 2 diabetics. Participants will receive an experimental medication once per week to determine its effectiveness in lowering blood sugar and bodyweight.
Would you like to take part?
As a volunteer in a research study, you’ll receive study-related medical care from the study doctor and regular follow-up of your health to monitor the effectiveness of the care you’ll receive. The results of this research will be used to find out if the investigational medication being studied will be of benefit to others struggling to manage type 2 diabetes, and whether it will be made widely available to all Canadians. Study volunteers are an important part of moving medical care forward.
You may qualify to participate in this study if you:
- Are 18 years of age or older at the time of providing informed consent
- Have a BMI greater than or equal to 30 kg/m^2 (You can calculate your BMI using this tool: https://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmicalc.htm)
- Have been diagnosed with type 2 diabetes 180 days or more before screening
- Have been on stable daily doses of the following anti-diabetic drugs or combination regiments at effective or maximum tolerated dose as judged by the investigator for greater than or equal to 90 days
- Metformin
- SGLT2 inhibitor
You may not qualify to participate if you:
- Suffer from chronic renal impairment
- Have been treated with any anti-diabetic or anti-obesity medication other than stated in the inclusion criteria within 90 days before screening
- Have any uncontrolled and potentially unstable diabetic retinopathy or maculopathy
- Have any planned initiation or change in concomitant medications known to affect weight or glucose metabolism
- Have any previous or planned obesity treatment with surgery or a weight loss device
- Are pregnant or plan to become pregnant during the duration of the study
- Have a history of chronic pancreatitis
- Have any disorder which in the investigator’s opinion might jeopardize the participant’s safety or compliance with the protocol
There are other eligibility requirements that the study doctor will review. Only the study doctor can finally determine whether you are eligible to participate in the study or not.